Reference:
- Li LG, Zhang YL. Review of rubber stoppers for pharmaceutical use and its compatibility with pharmaceutical products. Chin J Pharm. 2015;46:1366–1371.
- Kawasaki Y, Umemura T, Saito M, et al. Toxicity study of a rubber antioxidant, 2-mercaptobenzimidazole, by repeated oral administration to rats. J Toxicol Sci. 1998;23:53–68.
- Jenke D. A general strategy for the chemical aspects of the safety assessment of extractables and leachables in pharmaceutical drug products: the chemical assessment triad. PDA J Pharm Sci Tech. 2012;66:168–183.
- Jenke D, Carlson T. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems. PDA J Pharm Sci Tech. 2014;68:407–455.
- Broschard TH, Glowienke S, Bruen US, et al. Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics-Current challenges and approaches. Regul Toxicol Pharm. 2016;81:201–211.
- United States Pharmacopoeia 40, Appendix <381> Elastomeric closures for injections. 2017. p.326–331.
- European Pharmacopoeia 9.0, Appendix 3.1 Materials used for the manufacture of containers. 2017. p.391–392.
- Japanese Pharmacopoeia 17, Appendix 7.03 Test for rubber closure for aqueous infusions. 2016. p.172–174.
- National Pharmaceutical package Standard 2015, China Pharmaceutical Science and Technology Press. 2015.
- United States Pharmacopoeia 40, Appendix <1663> Assessment of extractables associated with pharmaceutical packaging/delivery systems. 2017. p.2020–2035.
- United States Pharmacopoeia 40, Appendix <1664> Assessment of drug product leachables associated with pharmaceutical packaging/delivery systems. 2017. p.2035–2047.
- Bouma K, Schothorst RC. Identification of extractable substances from rubber nettings used to package meat products. Food Addit Contam. 2003;20:300–307.
- Zhang F, Chang A, Karaisz K, et al. Structural identification of extractables from rubber closures used for pre-filled semisolid drug applicator by chromatography, mass spectrometry, and organic synthesis. J Pharm Biomed Anal. 2004;34:841–849.
- Wei YL, Wu Y, Zhu TL, et al. Identification of UV-absorbing extractables from rubber closures used in containers of injectable powder and safety assessment of leachables in the drug. J Pharm Biomed Anal. 2017;138:256–266.
- Zhang DS, Xue J, Wang C, et al. Critical quality attributes of cephalosporins for injection. Chin J New Drug. 2016;25:17–24.
- Zhao X, Hu CQ, Jin SH. The analysis of volatile substances of butylrubber closures. Chin J Pharm Anal. 2006;26:315–318.
- Zhao X, Hu CQ, Jin SH. Consideration and suggestion to estimate the compatibility between rubber closures and drugs. Chinese Pharmaceutical Affairs. 2007;21:810–812.
- Gao DL, Liu S, Wang YL. Quality assessment for domestic cefazolin sodium for injection. Chin J Antibiot. 2013;38:344–347.
- Zhao X, Hu CQ, Jin SH. The Effect of Rubber Closures on the Haze State of Ceftriaxone Sodium for Injection. Drug Dev Ind Pharm. 2007;33:35–44.
- Guidelines for testing the compatibility of Drug Packaging Materials with Drugs, YBB00142002-2015. http://www.nicpbp.org.cn/CL0822/
- Corredor CC, Tomasella FP, Young J. Drug interactions with potential rubber closure extractables. Identification of thiol-disulfide exchange reaction products of captopril and thiurams. J Chromatogr A. 2009;1216:43–48.
- Wei NY, Yu LJ, Yu ZX, et al. Determination of BHT in Methotrexate for injection by GC-MS. Chinese Pharmaceutical Affairs. 2011;25:591–593.
- Guidance for Industry, Container Closure Systems for Packaging Human Drugs and Biologics, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER),1999. https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm070551.pdf.
- LIU Y, HU CQ. Preliminary identification and quantification of residual solvents in pharmaceuticals using the parallel dual-column system. J Chromatogr A. 2007;1175:259–266.